Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

    Virtual Booth

    Contact Supplier

    Axplora is your partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    JUBLIA

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 6,712Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Taro’s Generics Efinaconazole Receives Tentative Approval in US
    Taro’s Generics Efinaconazole Receives Tentative Approval in US

    02 Mar 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212211

    FDA
    02 Mar 2026
    Share Share
    Alembic Pharma Gets FDA Nod for Generic Antifungal Solution
    Alembic Pharma Gets FDA Nod for Generic Antifungal Solution

    24 Feb 2026

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/alembic-pharma-gets-usfda-nod-to-market-generic-anti-fungal-solution/articleshow/128752400.cms

    ECONOMICTIMES
    24 Feb 2026
    Share Share
    Alembic’s Generics Efinaconazole Receives Approval in US
    Alembic’s Generics Efinaconazole Receives Approval in US

    23 Feb 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212027

    FDA
    23 Feb 2026
    Share Share
    Almirall Completes Efinaconazole Approval Procedure In Europe
    Almirall Completes Efinaconazole Approval Procedure In Europe

    15 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241014039794/en

    BUSINESSWIRE
    15 Oct 2024
    Share Share
    Zydus Pharm Generic Fingolimod HCL Receives Tentative Approval in the U.S.
    Zydus Pharm Generic Fingolimod HCL Receives Tentative Approval in the U.S.

    15 Jul 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212178

    FDA
    15 Jul 2022
    Share Share
    Lupin receives USFDA approval for anti-fungal drug
    Lupin receives USFDA approval for anti-fungal drug

    03 Mar 2022

    // BUSINESS-STANDARD

    https://www.business-standard.com/article/news-cm/lupin-receives-usfda-approval-for-anti-fungal-drug-122030300756_1.html

    BUSINESS-STANDARD
    03 Mar 2022
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.